Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy

Purpose To evaluate the long-term outcomes of patients with prostate cancer who have pathological pT3b N0–Nx, with postoperative PSA < 0.1 ng/ml and no systematic adjuvant treatment.